These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21786077)

  • 41. Blood-brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into the mechanism.
    Annunziata P
    J Neurol; 2003 Aug; 250(8):901-6. PubMed ID: 12928906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of HIV-1 TAT protein and methamphetamine exposure on visual discrimination and executive function in mice.
    Kesby JP; Fields JA; Chang A; Coban H; Achim CL; Semenova S;
    Behav Brain Res; 2018 Sep; 349():73-79. PubMed ID: 29709610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse.
    Gaskill PJ; Calderon TM; Luers AJ; Eugenin EA; Javitch JA; Berman JW
    Am J Pathol; 2009 Sep; 175(3):1148-59. PubMed ID: 19661443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.
    Gong Y; Zhi K; Nagesh PKB; Sinha N; Chowdhury P; Chen H; Gorantla S; Yallapu MM; Kumar S
    Viruses; 2020 May; 12(5):. PubMed ID: 32443728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms.
    Buch S; Yao H; Guo M; Mori T; Mathias-Costa B; Singh V; Seth P; Wang J; Su TP
    Curr HIV Res; 2012 Jul; 10(5):425-8. PubMed ID: 22591366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV-1 proteins, Tat and gp120, target the developing dopamine system.
    Fitting S; Booze RM; Mactutus CF
    Curr HIV Res; 2015; 13(1):21-42. PubMed ID: 25613135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amphetamine toxicities: classical and emerging mechanisms.
    Yamamoto BK; Moszczynska A; Gudelsky GA
    Ann N Y Acad Sci; 2010 Feb; 1187():101-21. PubMed ID: 20201848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
    Ramkissoon A; Wells PG
    Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disruption of blood-brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins.
    Sun Y; Cai M; Liang Y; Zhang Y
    J Neurovirol; 2023 Dec; 29(6):658-668. PubMed ID: 37899420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.
    Ferris MJ; Mactutus CF; Booze RM
    Neurosci Biobehav Rev; 2008 Jul; 32(5):883-909. PubMed ID: 18430470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple Faceted Roles of Cocaine in Potentiation of HAND.
    Cai Y; Yang L; Callen S; Buch S
    Curr HIV Res; 2016; 14(5):412-416. PubMed ID: 27009095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior.
    Saloner R; Fields JA; Marcondes MCG; Iudicello JE; von Känel S; Cherner M; Letendre SL; Kaul M; Grant I;
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):743-764. PubMed ID: 32929575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51.
    Sharma HS; Sjöquist PO; Ali SF
    Curr Pharm Des; 2007; 13(18):1903-23. PubMed ID: 17584116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of CNS Viral Seeding by HIV
    Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Central Nervous System Inflammation and Infection during Early, Nonaccelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques.
    Hsu DC; Sunyakumthorn P; Wegner M; Schuetz A; Silsorn D; Estes JD; Deleage C; Tomusange K; Lakhashe SK; Ruprecht RM; Lombardini E; Im-Erbsin R; Kuncharin Y; Phuang-Ngern Y; Inthawong D; Chuenarom W; Burke R; Robb ML; Ndhlovu LC; Ananworanich J; Valcour V; O'Connell RJ; Spudich S; Michael NL; Vasan S
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Permeability of the blood-brain barrier to HIV-1 Tat.
    Banks WA; Robinson SM; Nath A
    Exp Neurol; 2005 May; 193(1):218-27. PubMed ID: 15817280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders.
    Mediouni S; Marcondes MC; Miller C; McLaughlin JP; Valente ST
    Front Microbiol; 2015; 6():1164. PubMed ID: 26557111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.
    Kramer-Hämmerle S; Rothenaigner I; Wolff H; Bell JE; Brack-Werner R
    Virus Res; 2005 Aug; 111(2):194-213. PubMed ID: 15885841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS.
    Bednar MM; Sturdevant CB; Tompkins LA; Arrildt KT; Dukhovlinova E; Kincer LP; Swanstrom R
    Curr HIV/AIDS Rep; 2015 Jun; 12(2):262-71. PubMed ID: 25914150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice.
    Kesby JP; Markou A; Semenova S;
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):141-50. PubMed ID: 25476577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.